Back to top
more

Hologic (HOLX)

(Delayed Data from NSDQ)

$67.81 USD

67.81
4,294,477

-0.25 (-0.37%)

Updated Aug 15, 2025 04:00 PM ET

After-Market: $67.84 +0.03 (0.04%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth A Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 38% (152 out of 246)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Zacks.com featured highlights include: BJ's Wholesale Club, Dollar General, Repligen Corp, Hologic and Parker-Hannifin

by Zacks Equity Research

Zacks.com featured highlights include: BJ's Wholesale Club, Dollar General, Repligen Corp, Hologic and Parker-Hannifin

Zacks Equity Research

Medtronic (MDT) Integrates InPen With Guardian Connect

by Zacks Equity Research

Medtronic's (MDT) strategic acquisition of Companion Medical strengthens the company's data science and AI capabilities.

Zacks Equity Research

Buy These 3 Momentum Anomaly Stocks to Maximize Your Returns

by Zacks Equity Research

Hologic (HOLX), Logitech (LOGI) and Quidel (QDEL) are currently witnessing a short-term pullback in price. So make sure you're taking full advantage of it.

Sanghamitra Saha headshot

5 Top Stocks to Buy on Earnings Beat Potential

by Sanghamitra Saha

These top-ranked stocks are likely to beat on bottom line in their next releases.

Zacks Equity Research

CVS Health Prescription Volume Solid, Price Cut Woes Stay

by Zacks Equity Research

CVS Health's (CVS) consumer centric digital strategy is even more relevant amid the pandemic.

Nitish Marwah headshot

Explore These 5 Momentum Stocks Using Driehaus Strategy

by Nitish Marwah

Investors who have the propensity to take a higher risk can think of investing in momentum stocks to boost their gains.

Zacks Equity Research

Hologic (HOLX) is an Incredible Growth Stock: 3 Reasons Why

by Zacks Equity Research

Hologic (HOLX) could produce exceptional returns because of its solid growth attributes.

Zacks Equity Research

Top Ranked Growth Stocks to Buy for November 10th

by Zacks Equity Research

Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, November 10th

Zacks Equity Research

Hologic (HOLX) Q4 Earnings Surpass Estimates, Margins Rise

by Zacks Equity Research

Hologic (HOLX) exhibited robust segmental growth in fourth-quarter fiscal 2020 driven by strong performance by the Diagnostics segment amid the coronavirus pandemic.

Zacks Equity Research

Hologic (HOLX) Tops Q4 Earnings and Revenue Estimates

by Zacks Equity Research

Hologic (HOLX) delivered earnings and revenue surprises of 69.67% and 7.72%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Square (SQ) to Report Q3 Earnings: What's in the Cards?

by Zacks Equity Research

Square's (SQ) third-quarter results are likely to reflect portfolio strength amid the coronavirus pandemic.

Zacks Equity Research

What's in Store for Groupon (GRPN) This Earnings Season?

by Zacks Equity Research

Groupon's (GRPN) Q3 performance is expected to have benefited from ongoing growth strategy. However, lower bookings in travel and for restaurants are likely to have affected the top line.

Zacks Equity Research

Why Earnings Season Could Be Great for Hologic (HOLX)

by Zacks Equity Research

Hologic (HOLX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Zacks Equity Research

What's in Store for Zillow Group (ZG) This Earnings Season?

by Zacks Equity Research

Zillow Group's (ZG) Q3 performance is likely to benefit from robust demand for Zillow Offers. However, prevailing uncertainties in the market due to the pandemic are likely to have hampered performance of Homes segment.

Zacks Equity Research

Factors Setting the Tone for Axcelis' (ACLS) Q3 Earnings

by Zacks Equity Research

Axcelis' (ACLS) third-quarter 2020 performance is expected to reflect gains from solid uptick in demand for its solutions across logic, flash, foundry and advanced memory customers.

Zacks Equity Research

What's in Store for Cloudflare (NET) This Earnings Season?

by Zacks Equity Research

Cloudflare's (NET) Q3 results are likely to reflect benefits from its recurring subscription-based business model and a diversified customer base despite the coronavirus crisis.

Zacks Equity Research

What's in Store for NortonLifeLock (NLOK) This Earnings Season?

by Zacks Equity Research

NortonLifeLock's (NLOK) Q2 results to reflect benefits from increased demand for cybersecurity and ID analytics solutions amid the COVID-19 pandemic-led work-from-home and online-learning wave.

Zacks Equity Research

What's in Store for Paycom (PAYC) This Earnings Season?

by Zacks Equity Research

Paycom's (PAYC) Q3 results likely to reflect benefits from new business wins and high-margin recurring revenue business.

Zacks Equity Research

What's in Store for Tyler (TYL) This Earnings Season?

by Zacks Equity Research

Delays in procurement processes and lengthening sales cycles, as the public sector entities focus on issues related to the pandemic, are likely to have hurt Tyler's (TYL) Q3 performance.

Zacks Equity Research

What's in Store for ChannelAdvisor (ECOM) This Earnings Season?

by Zacks Equity Research

ChannelAdvisor's (ECOM) Q3 performance is likely to have gained from demand surge for cloud-based solutions as retailers are spending more on boosting their online sales performance amid the pandemic.

Zacks Equity Research

DXC Technology (DXC) to Report Q2 Earnings: What's in Store?

by Zacks Equity Research

Soft IT spending as organizations are pushing back their big and expensive technology investments, due to the slowdown concerns amid the pandemic, is likely to have hurt DXC's Q2 performance.

Zacks Equity Research

Donnelley (DFIN) to Report Q3 Earnings: What's in the Cards?

by Zacks Equity Research

Sluggish compliance filing transactional activities due to the pandemic-related shutdowns and business disruptions are likely to have hurt Donnelley's (DFIN) Q3 performance.

Zacks Equity Research

Will Hologic (HOLX) Beat Estimates Again in Its Next Earnings Report?

by Zacks Equity Research

Hologic (HOLX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks Equity Research

Can Diagnostics Aid Hologic (HOLX) Q4 Sales Amid Coronavirus?

by Zacks Equity Research

Strength in Molecular Diagnostics business is likely to have continued to aid Hologic's (HOLX) performance in the fourth quarter of fiscal 2020 amid the coronavirus-led economic doldrums.

Zacks Equity Research

Hologic (HOLX) Earnings Expected to Grow: Should You Buy?

by Zacks Equity Research

Hologic (HOLX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.